Vicarious Surgical Inc. (RBOT)
NYSE: RBOT · IEX Real-Time Price · USD
0.315
+0.018 (5.88%)
At close: May 31, 2024, 4:00 PM
0.341
+0.026 (8.09%)
After-hours: May 31, 2024, 7:37 PM EDT
Vicarious Surgical Market Cap
Vicarious Surgical has a market cap or net worth of $55.47 million as of May 31, 2024. Its market cap has decreased by -81.24% in one year.
Market Cap
55.47M
Enterprise Value
-15.00M
1-Year Change
-81.24%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since July 15, 2020, Vicarious Surgical's market cap has decreased from $313.40M to $55.47M, a decrease of -82.30%. That is a compound annual growth rate of -36.03%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 30, 2024 | 43.90M | -0.68% |
May 29, 2024 | 44.20M | -9.24% |
May 28, 2024 | 48.70M | -5.44% |
May 24, 2024 | 51.50M | -6.19% |
May 23, 2024 | 54.90M | -10.73% |
May 22, 2024 | 61.50M | 17.59% |
May 21, 2024 | 52.30M | -6.77% |
May 20, 2024 | 56.10M | -9.66% |
May 17, 2024 | 62.10M | 27.78% |
May 16, 2024 | 48.60M | 7.28% |
May 15, 2024 | 45.30M | -6.79% |
May 14, 2024 | 48.60M | 15.71% |
May 13, 2024 | 42.00M | -1.64% |
May 10, 2024 | 42.70M | -1.61% |
May 9, 2024 | 43.40M | -2.47% |
May 8, 2024 | 44.50M | -0.22% |
May 7, 2024 | 44.60M | 0.68% |
May 6, 2024 | 44.30M | -2.85% |
May 3, 2024 | 45.60M | 2.93% |
May 2, 2024 | 44.30M | 7.00% |
May 1, 2024 | 41.40M | - |
Apr 30, 2024 | 41.40M | 0.49% |
Apr 29, 2024 | 41.20M | -13.26% |
Apr 26, 2024 | 47.50M | 2.81% |
Apr 25, 2024 | 46.20M | -3.75% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Anebulo Pharmaceuticals | 54.46M |
Carisma Therapeutics | 54.42M |
IceCure Medical | 53.82M |
Rockwell Medical | 53.66M |
Mobile-health Network Solutions | 52.70M |
Equillium | 51.82M |
Lexaria Bioscience | 51.41M |
Carmell Therapeutics | 50.97M |